157 related articles for article (PubMed ID: 24412602)
21. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
[TBL] [Abstract][Full Text] [Related]
22. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of HBV-DNA replication and expression by siRNA based on magnetic nanoparticles transfering in HepG2 2.2.15 cells.
He Y; Jiang Y; Wang G; Luo H; Xiao X; Deng C; Luo K; Su X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):543-8. PubMed ID: 20622325
[TBL] [Abstract][Full Text] [Related]
24. [Down-regulation of hepatitis B virus replication by heparin sulfate-D-glucosaminyl-3-O-sulfotransferase 3B1].
Su HB; Luo Q; Zhang ZZ; Hu JL; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):417-22. PubMed ID: 22053370
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.
Wei W; Wang SF; Yu B; Ni M
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):828-832. PubMed ID: 29270739
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus.
Delaney WE; Isom HC
Hepatology; 1998 Oct; 28(4):1134-46. PubMed ID: 9755254
[TBL] [Abstract][Full Text] [Related]
27. [Inhibition of hepatitis B virus by combined siRNAs in vitro].
Ye JJ; Xu ZF; Chen Z; Cao J; Zheng S; Ding JY
Shi Yan Sheng Wu Xue Bao; 2005 Apr; 38(2):141-7. PubMed ID: 16011247
[TBL] [Abstract][Full Text] [Related]
28. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
[TBL] [Abstract][Full Text] [Related]
29. [Long-fragment RNA inhibits hepatitis B virus gene replication and expression in HepG2.2.15 cells].
Tian L; He S; Li X; Hu WY; Peng PL; Wang F; Gao CY; Ren H; Tang KF
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):44-7. PubMed ID: 21272458
[TBL] [Abstract][Full Text] [Related]
30. [Construction of recombinant eukaryotic expression plasmid containing 1.3-fold-overlength genome of HBV and its expression in HepG2 cells].
Tang N; Huang AL; Zhang BQ; Yan G; Xiang MQ; Pu D; Guo H
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):464-6. PubMed ID: 12939176
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
[TBL] [Abstract][Full Text] [Related]
32. Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cells metastasis.
Zhang Y; Li Y; Ma Y; Liu S; She Y; Zhao P; Jing M; Han T; Yan C; Wu Z; Gao J; Ye L
Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G565-73. PubMed ID: 21719740
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
34. miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma.
Wu HJ; Zhuo Y; Zhou YC; Wang XW; Wang YP; Si CY; Wang XH
World J Gastroenterol; 2017 Jul; 23(25):4569-4578. PubMed ID: 28740345
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
Zhao ZF; Yang H; Han DW; Zhao LF; Zhang GY; Zhang Y; Liu MS
World J Gastroenterol; 2006 Oct; 12(37):6046-9. PubMed ID: 17009407
[TBL] [Abstract][Full Text] [Related]
36. Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication.
Kunanopparat A; Issara-Amphorn J; Leelahavanichkul A; Sanpavat A; Patumraj S; Tangkijvanich P; Palaga T; Hirankarn N
World J Gastroenterol; 2018 Sep; 24(34):3861-3870. PubMed ID: 30228780
[TBL] [Abstract][Full Text] [Related]
37. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
[TBL] [Abstract][Full Text] [Related]
38. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
[TBL] [Abstract][Full Text] [Related]
39. [Inhibition of HBV replication and antigen expression by RNA interference against different targets].
Zhang BQ; Huang Y; Tang N; Wu Y; Zhang J; Chen WX; He TC; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):662-5. PubMed ID: 16995979
[TBL] [Abstract][Full Text] [Related]
40. Targeted HBx gene editing by CRISPR/Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells.
Rawal P; Tripathi DM; Hemati H; Kumar J; Tyagi P; Sarin SK; Nain V; Kaur S
Liver Int; 2024 Feb; 44(2):614-624. PubMed ID: 38105495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
